MAP2K7 and melanoma: A sharp increase in thapsigargin toxicity when combined with pyridinyl imidazole compounds was also observed in A375 melanoma cells treated with SB590885, but not when thapsigargin was combined with the MEK inhibitor PD184352 (Figure 7C).